Free Trial

Cartesian Therapeutics (RNAC) Institutional Ownership

Cartesian Therapeutics logo
$10.23 -0.14 (-1.35%)
As of 05/20/2025 04:00 PM Eastern

Institutional Ownership Changes (13F Filings) for Cartesian Therapeutics (NASDAQ:RNAC)

Current
Institutional Ownership
Percentage
86.95%
Number of
Institutional Buyers
(last 12 months)
34
Total
Institutional Inflows
(last 12 months)
$58.40M
Number of
Institutional Sellers
(last 12 months)
14
Total
Institutional Outflows
(last 12 months)
$77.79M
Get RNAC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cartesian Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

RNAC Institutional Buying and Selling by Quarter

Cartesian Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2025 Goldman Sachs Group Inc.15,775$208K0.0%-42.7%0.061%
5/16/2025 683 Capital Management LLC150,000$1.98M0.1%+20.0%0.578%
5/15/2025 MPM Bioimpact LLC790,779$10.42M1.8%+9.7%3.049%
5/15/2025 Siren L.L.C.563,272$7.42M0.4%-1.6%2.172%
5/14/2025 AlphaQuest LLC7,191$95K0.0%N/A0.028%
5/14/2025 Erste Asset Management GmbH260,011$3.43M0.0%+49.8%1.002%
5/13/2025 Twin Focus Capital Partners LLC15,000$198K0.0%+25.0%0.058%
5/12/2025 Nuveen LLC27,869$367K0.0%N/A0.107%
5/9/2025 Deutsche Bank AG7,424$98K0.0%+104.1%0.029%
5/9/2025 Charles Schwab Investment Management Inc.29,303$386K0.0%+9.3%0.113%
4/30/2025 Alps Advisors Inc.19,392$256K0.0%-5.6%0.075%
4/29/2025 Bank of New York Mellon Corp20,937$276K0.0%+7.9%0.081%
4/8/2025 Rhumbline Advisers13,006$171K0.0%+27.5%0.050%
2/17/2025 Two Sigma Investments LP11,812$212K0.0%-8.5%0.046%
2/17/2025 MPM Bioimpact LLC721,139$12.92M1.8%+14.6%2.837%
2/17/2025Nuveen Asset Management LLC72,099$1.29M0.0%+197.8%0.284%
2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.5,786$104K0.0%+44.8%0.023%
2/17/2025 Citadel Advisors LLC315,000$5.64M0.0%-16.2%1.239%
2/17/2025 Bank of America Corp DE11,690$209K0.0%+54.4%0.046%
2/17/2025 683 Capital Management LLC125,000$2.24M0.1%+65.7%0.492%
2/14/2025 Northern Trust Corp95,030$1.70M0.0%+50.6%0.374%
2/14/2025 Virtus ETF Advisers LLC3,533$63K0.0%N/A0.014%
2/14/2025 MetLife Investment Management LLC6,667$119K0.0%N/A0.026%
2/13/2025 Barclays PLC19,099$342K0.0%+64.5%0.075%
2/13/2025 Renaissance Technologies LLC13,800$247K0.0%N/A0.054%
2/13/2025 Wells Fargo & Company MN4,847$87K0.0%+112.7%0.019%
2/12/2025 Geode Capital Management LLC221,257$3.96M0.0%+63.0%0.870%
2/12/2025 JPMorgan Chase & Co.274,740$4.92M0.0%-11.1%1.081%
2/11/2025 Corebridge Financial Inc.5,122$92K0.0%+32.6%0.020%
2/10/2025 Erste Asset Management GmbH173,566$3.26M0.0%-93.6%0.683%
2/6/2025 Charles Schwab Investment Management Inc.26,803$480K0.0%+40.7%0.105%
2/4/2025 Bank of New York Mellon Corp19,407$348K0.0%+28.5%0.076%
1/31/2025 New York State Common Retirement Fund3,902$70K0.0%-23.5%0.015%
1/30/2025 Rhumbline Advisers10,201$183K0.0%+10.0%0.040%
1/27/2025 Mirae Asset Global Investments Co. Ltd.4,562$82K0.0%+22.8%0.018%
1/24/2025 China Universal Asset Management Co. Ltd.5,389$97K0.0%N/A0.021%
12/26/2024 JPMorgan Chase & Co.309,018$4.98M0.0%+0.9%1.216%
11/19/2024 Barclays PLC11,611$188K0.0%+208.6%0.046%
11/16/2024 Geode Capital Management LLC135,700$2.19M0.0%+2.1%0.534%
11/15/2024 Barclays PLC11,611$188K0.0%+208.6%0.046%
Gold Hits New Highs as Global Markets Spiral (Ad)

When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.

Go Here to Learn What's Happening and How to Prepare >>
11/15/2024 State Street Corp157,495$2.54M0.0%+2.5%0.620%
11/15/2024 Ikarian Capital LLC52,193$841K0.1%-78.5%0.205%
11/13/2024 Great Point Partners LLC200,000$3.22M0.9%N/A0.787%
11/13/2024 BNP Paribas Financial Markets1,651$27K0.0%+122.5%0.006%
11/13/2024 FMR LLC2,851,830$45.97M0.0%+458.3%11.219%
10/23/2024Lake Street Advisors Group LLC15,822$255K0.0%-50.0%0.074%
9/16/2024 Point72 DIFC Ltd1,725$47K0.0%N/A0.008%
9/16/2024 Cubist Systematic Strategies LLC13,010$351K0.0%N/A0.061%
9/16/2024 Point72 Asia Singapore Pte. Ltd.1,824$49K0.0%N/A0.009%
8/27/2024 Logos Global Management LP90,000$2.43M0.2%N/A0.506%
8/15/2024 Point72 Asia Singapore Pte. Ltd.1,824$49K0.0%N/A0.009%
8/14/2024 Cubist Systematic Strategies LLC13,010$351K0.0%N/A0.061%
8/14/2024 Point72 DIFC Ltd1,725$47K0.0%N/A0.008%
8/14/2024 Marshall Wace LLP30,038$811K0.0%N/A0.140%
8/14/2024 Logos Global Management LP90,000$2.43M0.2%N/A0.421%
8/9/2024 Renaissance Technologies LLC17,052$461K0.0%-96.9%0.096%
8/6/2024Lake Street Advisors Group LLC31,644$855K0.0%N/A0.178%
8/1/2024 Rhumbline Advisers8,487$229K0.0%-93.5%0.048%
7/26/2024 Bank of New York Mellon Corp19,916$538K0.0%-93.7%0.112%
7/22/2024 Hall Laurie J Trustee1,759$48K0.0%-96.7%0.010%
5/17/2024 Artal Group S.A.9,136,635$5.94M0.2%N/A171.098%
5/14/2024 American International Group Inc.56,202$37K0.0%N/A1.052%
5/10/2024 Vanguard Group Inc.6,315,113$4.11M0.0%N/A118.172%
5/7/2024 SG Americas Securities LLC47,134$31K0.0%N/A0.883%
5/3/2024Delphi Financial Group Inc.660,852$430K0.3%N/A12.261%
5/1/2024 BNP Paribas Financial Markets59,125$38K0.0%N/A1.097%
4/23/2024 Hall Laurie J Trustee52,775$34K0.0%N/A0.979%
(Data available from 1/1/2016 forward)

RNAC Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of RNAC shares?

During the previous two years, 47 institutional investors and hedge funds held shares of Cartesian Therapeutics. The most heavily invested institutionals were FMR LLC ($45.97M), MPM Bioimpact LLC ($10.42M), Siren L.L.C. ($7.42M), Artal Group S.A. ($5.94M), Citadel Advisors LLC ($5.64M), JPMorgan Chase & Co. ($4.92M), and Vanguard Group Inc. ($4.11M).Learn more on RNAC's institutional investors.

What percentage of Cartesian Therapeutics stock is owned by institutional investors?

86.95% of Cartesian Therapeutics stock is owned by institutional investors. Learn more on RNAC's institutional investor holdings.

Which institutional investors have been buying Cartesian Therapeutics stock?

Of the 40 institutional investors that purchased Cartesian Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Artal Group S.A. ($9.14M), Vanguard Group Inc. ($6.32M), FMR LLC ($2.34M), Delphi Financial Group Inc. ($660.85K), Great Point Partners LLC ($200K), Logos Global Management LP ($180K), and MPM Bioimpact LLC ($161.36K).

How much institutional buying is happening at Cartesian Therapeutics?

Institutional investors have bought a total of 19,766,410 shares in the last 24 months. This purchase volume represents approximately $376.80M in transactions.

Which Cartesian Therapeutics major shareholders have been selling company stock?

Of the 14 institutional investors that sold Cartesian Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Erste Asset Management GmbH ($2.53M), Renaissance Technologies LLC ($536.55K), Bank of New York Mellon Corp ($297.41K), Ikarian Capital LLC ($190.18K), Rhumbline Advisers ($121.40K), Citadel Advisors LLC ($60.77K), and Hall Laurie J Trustee ($51.02K).

How much institutional selling is happening at Cartesian Therapeutics?

Institutional investors have sold a total of 3,858,581 shares in the last 24 months. This volume of shares sold represents approximately $77.79M in transactions.



This page (NASDAQ:RNAC) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners